Rain Check, Please! Truly Hard Seltzer is Paying Fans with a “Rain Check” to Use on Their Next Pack If Fourth of July Plans Get Rained Out We can’t guarantee the weather, but we can guarantee delicious fruity refreshment with the new, limited-edition Truly Pool Party Variety Pack BOSTON, MA, June 18, 2025 (GLOBE NEWSWIRE) -- Summer weather can be unpredictable – and nothing puts a damper on a holiday weekend like a rained-out pool party. With recent rainfall trends tracking higher than usual1 and forecasts pointing to a wetter-than-average summer in portions of the nation2, it’s safe to...
Dogfish Head Dubbed Official Beer of JAWS 50th Anniversary Celebrations MILTON, Del., June 18, 2025 (GLOBE NEWSWIRE) -- “We’re gonna need a bigger boat” … er, beer! joins forces with the Martha’s Vineyard Chamber of Commerce to celebrate the 50th anniversary of the iconic shark film, JAWS. As the “Official Beer of JAWS 50th Anniversary Celebrations,” Dogfish Head and its products will be prominently featured at the Martha Vineyard Chamber of Commerce’s happening this weekend – Friday, June 20, and Saturday, June 21 – on Martha’s Vineyard, where the original film was shot. Drinkers wil...
Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2025 DENVER, June 18, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced it will report financial results for the thirteen week period ended May 31, 2025, on Thursday, July 10, 2025, before market open. The Company will host a conference call to discuss these results with additional comments and details provided at that time. Particip...
Weatherford Announces Second-Quarter 2025 Conference Call HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, July 23, 2025 to discuss the Company’s results for the second quarter ended June 30, 2025. The conference call will begin at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). Prior to the conference call, the Company will issue a press release announcing the results and the associated presentation slides will be uploaded to the investor relations section of the Weatherfor...
FibroGen Announces 1-for-25 Reverse Stock Split SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGen’s common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the Company’s existing trading symbol “FGEN,” with the new CUSIP number 31572Q881. The Reverse Stock Split was previously approved by stockholders at the Compa...
SAMUEL ADAMS AWARDS MOOR’S BREWING CO 2025 BREWING & BUSINESS EXPERIENCESHIP Brewing the American Dream Program Continues Legacy of Small Business Support with New Top Craft Brewer Selection Boston, MA, June 12, 2025 (GLOBE NEWSWIRE) -- , the philanthropic program supporting food and beverage entrepreneurs nationwide, proudly announces Moor’s Brewing Co. as the 2025 winner of its prestigious Brewing & Business Experienceship. Now in its 14th year, the program welcomes this standout craft brewer into an esteemed community of innovators and changemakers in the beer industry. Each year, ...
Moody's Ratings (Moody's) assigned a Caa2 rating to KLX Energy Services Holdings, Inc.'s (KLXE) senior secured notes due 2030 and changed the ratings outlook to stable from negative. The Caa1 Corporate Family Rating (CFR) and Caa1-PD Probability of Default Rating (PDR) were affirmed. The Speculative...
AMERANT BANK ANNOUNCES HIRE OF ELLIOT SHAFER AS NEW HEAD OF BUSINESS DEVELOPMENT MIAMI, FL, June 09, 2025 (GLOBE NEWSWIRE) -- Amerant Bank, Florida’s bank of choice with a growing presence across South Florida, has named Elliot Shafer as SVP, Head of Business Development. In this key role, Shafer will support Amerant’s growth by identifying, evaluating, and pursuing business opportunities that align with Amerant’s strategic objectives across all lines of business. “We are excited to welcome Elliot to the team,” said Jerry Plush, Chairman and CEO. “His extensive experience in business d...
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. “Michael is a well-recognized biotech industry veteran, who brings a wealth of biotech leadership experience to our board,” said James Schoeneck, chairman of the board of directors of FibroGen. “His expertise spanning all stages of drug development will be invaluable as FibroGen progresses its pipeline. Michael’s deep understanding o...
TWISTED TEA HARD ICED TEA UNLEASHES ITS BEST SUMMER LINEUP YET WITH A DELICIOUSLY REFRESHING FLAVOR FOR EVERY FAN Rocket Pop returns, Extreme goes national, and Light gets loud, proving no one does summer quite like Twisted Tea BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- If you needed an excuse to crack open an ice-cold can of Twisted Tea Hard Iced Tea, let this be it! This summer, America’s favorite hard iced tea* is bringing more flavor to fans across the country with a lineup as bright and colorful as the Fourth of July. Whether you’re feeling nostalgic, looking to turn up the flavor o...
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced an update on the Phase 2 IGNITE open-label clinical trial evaluating iluzanebart, a monoclonal antibody TREM2 agonist, for the potential treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Iluzanebart demonstrated a favorable saf...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.